Folio · SPXSet Report · Digest
v0.7.0 STABLE · 2026-11-11 · r4

2026-W46 · Nov 9–Nov 15 · Company · Profile · published

Index >>> Company >>> Profile

DuPont de Nemours, Inc. (DD) — XLI Industrials · S&P 500 Profile |杜邦介紹

materialsS&P500xlbxlb-top-25
SPXSet Studio
IN-HOUSE RESEARCH · 站內獨立研究

DuPont de Nemours, Inc. (DD) — Business, History & S&P 500 Profile |杜邦介紹

DuPont company profile · specialty materials & chemicals (healthcare & water, diversified industrials) · history · financial snapshot · S&P 500 rank #397 · 杜邦公司業務歷史財務與標普500地位

中文版 ↓

PROFILE
Market data as of Nov 3, 2026 (frozen benchmark)
Financials: FY2025 (ended Dec 31, 2025)
MARKET CAP
$20.54B
Nov 3, 2026 · Slickcharts (frozen benchmark)
S&P 500 WEIGHT
0.03%
Rank #397 · Nov 3, 2026 (Slickcharts)
FY2025 REVENUE
$6.8B
+2% organic, continuing operations
FY2025 INCOME (CONTINUING OPS)
$98M
GAAP income from continuing operations

SNAPSHOT

TickerDD (NYSE)
CompanyDuPont de Nemours, Inc.
GICS sector / industryMaterials (XLB) / Specialty Chemicals
S&P 500 rank (by weight)#397 · 0.03% (Nov 3, 2026)
Sector rank (by market cap)#19 in Materials (Nov 3, 2026)
Share price (frozen benchmark)$152.13 (Nov 3, 2026)
HeadquartersWilmington, Delaware
Founded1802 (E. I. du Pont; current DuPont de Nemours formed 2019)
CEOLori D. Koch (Chief Executive Officer, since June 1, 2024)
Employeesapproximately 15,000 as of December 31, 2025
Market cap$20.54B (Nov 3, 2026)

WHAT IT DOES

DuPont de Nemours is a specialty materials and chemicals company whose brands — Kevlar, Tyvek, Nomex, Corian and Great Stuff — serve healthcare, water purification, electronics, construction and safety markets, with its headquarters in Wilmington, Delaware.

The model is science at a premium: patented materials sold into regulated, specification-driven end markets. FY2025 results are reported on a continuing-operations basis only, because the Electronics business was separated as Qnity Electronics, Inc. on Nov 1, 2025 (distribution to holders of record Oct 22, 2025) and is shown as discontinued operations from Q4 2025, with comparatives restated. Continuing net sales were $6.8B, up 2% (organic +2%), GAAP income from continuing operations was $98M (versus a -$96M loss in 2024), GAAP EPS from continuing operations was $0.21, adjusted EPS was $1.68, up 16%, and operating EBITDA was $1.63B, up 6%.

This profile reports no single consolidated GAAP operating-income headline for DuPont, because the company does not headline one on this basis — the continuing-operations income figure is used with that label, and pre-separation total-company figures (about $12.9B) are never mixed with it.

BUSINESS SEGMENTS — FY2025

SegmentRevenueShareYoY
Healthcare & Water Technologies—+9% net sales, +7% organic—
Diversified Industrials—-3% net sales, -2% organic—
Source: DuPont FY2025 release segment growth rates. Absolute segment sales are not stated in the sources used and are shown as —; growth rates are stated, not derived. Continuing-operations basis only.

HISTORY

YearMilestone
1802E. I. du Pont founds the company as a gunpowder maker in Delaware
2017DowDuPont merger creates the combined company
2019DuPont de Nemours emerges as the specialty-products company after the three-way split
2024Lori D. Koch becomes CEO on June 1, succeeding Edward D. Breen
2025Electronics business separated as Qnity on Nov 1; aramids business sale to Arclin announced Aug 29 (cash $1.2B plus a $300M note and $325M equity consideration), expected to close Q1 2026; FY2025 continuing net sales $6.8B

COMPETITIVE POSITION

  • Brands — Kevlar, Tyvek and Nomex carry specification lock-in.
  • Healthcare & water — the growth segment, up 9% in net sales in FY2025.
  • Portfolio reshaping — Qnity separated and aramids agreed for sale.
  • Cyclical industrials — Diversified Industrials fell 3% in net sales in FY2025.
  • Competition — 3M, Honeywell, Celanese and other specialty makers contest the same niches.

FINANCIAL SNAPSHOT — FY2025

Net sales (continuing operations)$6.8B (+2%; organic +2%)
GAAP income from continuing operations / EPS$98M (vs -$96M) / $0.21
Adjusted EPS (stated separately)$1.68 (+16%)
Operating EBITDA$1.63B (+6%)
Q4 2025 net sales / GAAP loss from continuing ops / Adjusted EPS$1.7B (flat) / -$108M / $0.46; operating EBITDA $409M
Source: DuPont FY2025 release (Feb 10, 2026). CONTINUING-OPERATIONS BASIS ONLY. Do not mix the $6.8B continuing figure with pre-separation total-company guidance/sales of about $12.9B. Full-year cash from operations from continuing operations was $560M including $462M of separation-related costs; transaction-adjusted free cash flow was $689M. Employee count is approximately 15,000 as of December 31, 2025 (FY2025 10-K Item 1); the 22,500–28,000 range in earlier profiles belongs to the pre-separation company.

KEY RISKS

  • Portfolio execution — the aramids sale and Qnity separation must close cleanly.
  • Cyclical demand — construction and industrial volumes follow the cycle.
  • Litigation — PFAS and legacy liabilities remain a tail risk.
  • Input costs — feedstock and energy prices squeeze specialty margins.
  • Competition — Asian specialty makers contest water and electronics niches.

WHY IT MATTERS FOR THE S&P 500

DuPont is the S&P 500's specialty-chemicals name: at a 0.03% index weight and #19 in Materials by market cap, it carries the sector top-25 tag — one of only four in this batch.

Its post-separation shape is a standing read on whether portfolio reshaping creates a faster-growing specialty company.

SOURCES & METHODOLOGY

Market dataSlickcharts S&P 500 by weight (rank, weight, price — Nov 3, 2026 close) and Slickcharts S&P 500 analysis page (market cap)
FinancialsDuPont FY2025 results, release dated Feb 10, 2026 (fiscal year ended Dec 31, 2025; continuing operations basis after the Qnity separation), company profile sources
Sector classificationGICS (Specialty Chemicals) via the List of S&P 500 companies (Wikipedia)
Library dataSPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information.

Price Chart — 10-Year Monthly Candles

DD

Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com

FINANCIALS

繁體中文版

公司快照

代碼DD(NYSE)
公司DuPont de Nemours, Inc.
GICS 板塊/行業材料(XLB)/特種化學品
標普500排名(按權重)#397 · 0.03%(2026 年 11 月 3 日)
板塊內排名(按市值)材料第 #19(2026 年 11 月 3 日)
股價(凍結基準)$152.13(2026 年 11 月 3 日)
總部美國特拉華州威爾明頓
成立1802 年(E. I. du Pont;現杜邦公司成立於 2019 年)
行政總裁Lori D. Koch(行政總裁,自 2024 年 6 月 1 日起)
員工約 15,000(截至 2025 年 12 月 31 日)
市值$20.54B(2026 年 11 月 3 日)

業務概覽

杜邦是一家特種材料與化學品公司,旗下品牌——Kevlar、Tyvek、Nomex、Corian 與 Great Stuff——服務醫療保健、水淨化、電子、建築與安全市場,總部位於特拉華州威爾明頓。

其模式為溢價科學:專利材料銷往受監管、規格驅動的終端市場。FY2025 業績僅按持續經營口徑申報,因電子業務已於 2025 年 11 月 1 日分拆為 Qnity Electronics, Inc.(向 2025 年 10 月 22 日登記持有人分派),自 2025 年第四季度起列為終止經營,比較數字已重列。持續經營淨銷售為 $6.8B,增長 2%(有機增長 +2%),持續經營 GAAP 收益為 $98M(對比 -$96M 虧損),持續經營 GAAP 每股收益為 $0.21,經調整每股收益為 $1.68,增長 16%,營業 EBITDA 為 $1.63B,增長 6%。

本介紹不為杜邦列出單一合併 GAAP 營業利潤標題,因公司在此口徑下並無此標題——持續經營收益數字以該標籤使用,分拆前公司整體數字(約 $12.9B)絕不與之相混。

業務板塊 — FY2025

板塊收入佔比同比
醫療保健與水技術—淨銷售 +9%、有機 +7%—
多元化工業—淨銷售 -3%、有機 -2%—
來源:杜邦 FY2025 公告板塊增長率。板塊絕對銷售未見於所用來源,記為 —;增長率為申報數字,並非推算。僅為持續經營口徑。

歷史沿革

年份里程碑
1802E. I. du Pont 在特拉華州創立公司,起初為火藥製造商
2017陶氏杜邦合併成立合併公司
2019三方分拆後,杜邦公司成為特種產品公司
2024Lori D. Koch 於 6 月 1 日出任行政總裁,接替 Edward D. Breen
2025電子業務於 11 月 1 日分拆為 Qnity;8 月 29 日公告向 Arclin 出售芳綸業務(現金 $1.2B 加 $300M 票據與 $325M 股權對價),預計 2026 年第一季度完成;FY2025 持續經營淨銷售 $6.8B

競爭地位

  • 品牌——Kevlar、Tyvek 與 Nomex 具規格鎖定。
  • 醫療保健與水——增長板塊,FY2025 淨銷售增長 9%。
  • 組合重塑——Qnity 已分拆,芳綸業務已協議出售。
  • 週期性工業——多元化工業 FY2025 淨銷售下跌 3%。
  • 競爭——3M、Honeywell、Celanese 等特種製造商爭奪同一利基。

財務快照 — FY2025

淨銷售(持續經營)$6.8B(+2%;有機 +2%)
持續經營 GAAP 收益/每股收益$98M(對比 -$96M)/$0.21
經調整每股收益(分開列示)$1.68(+16%)
營業 EBITDA$1.63B(+6%)
2025 年第四季度淨銷售/持續經營 GAAP 虧損/經調整每股收益$1.7B(持平)/-$108M/$0.46;營業 EBITDA $409M
來源:杜邦 FY2025 公告(2026 年 2 月 10 日)。僅為持續經營口徑。切勿將 $6.8B 持續經營數字與分拆前公司整體指引/銷售約 $12.9B 相混。全年持續經營經營現金流為 $560M(含 $462M 分拆相關成本);交易調整後自由現金流為 $689M。員工數字約 15,000,截至 2025 年 12 月 31 日(FY2025 10-K Item 1);22,500–28,000 的區間見於較早簡介,屬於分拆前的公司。

主要風險

  • 組合執行——芳綸出售與 Qnity 分拆須乾淨完成。
  • 週期需求——建築與工業銷量跟隨週期。
  • 訴訟——PFAS 與歷史負債仍是尾部風險。
  • 投入成本——原料與能源價格擠壓特種產品利潤率。
  • 競爭——亞洲特種製造商爭奪水與電子利基。

對標普500的重要性

杜邦是標普500的特種化學品標的:指數權重 0.03%、材料板塊市值第 #19,持有板塊前 25 標籤——本批僅四家之一。

其分拆後形態,是組合重塑能否造就增長更快的特種公司之常設讀數。

來源與方法

市場數據Slickcharts 標普500權重榜(排名、權重、價格——2026 年 11 月 3 日收盤)及 Slickcharts 標普500分析頁(市值)
財務杜邦 FY2025 業績,2026 年 2 月 10 日公告(財政年度截至 2025 年 12 月 31 日;Qnity 分拆後的持續經營口徑)、公司簡介來源
板塊分類GICS(特種化學品),據 S&P 500 公司清單(Wikipedia)
圖庫數據SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。 SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。

10年股價K線圖(月K)

DD

來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份) · SPXSet.com

財報

SPXSet Studio

SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。

SPXSet · Company Library · DD
Data as of Nov 3, 2026 · Financials FY2025 (10-K) · Market data Nov 2026
Previous · NRG Energy, Inc. (NRG) — XLU Utilities · S&P 500 Profile |NRG能源介紹Next · Broadridge Financial Solutions, Inc. (BR) — XLI Industrials · S&P 500 Profile |博德瑞吉介紹

Entered 2026-11-03 22:54 · updated 2026-11-14 13:33 · rev 6